Cutler Group LP Biomea Fusion, Inc. Put Options Transaction History
Cutler Group LP
- $307 Million
- Q1 2024
Put Options
3 transactions
Others Institutions Holding BMEA
# of Institutions
99Shares Held
23.2MCall Options Held
1.08MPut Options Held
359K-
Heights Capital Management, Inc San Francisco, CA3.84MShares$6.8 Million1.84% of portfolio
-
Cormorant Asset Management, LP Boston, MA3.57MShares$6.32 Million0.65% of portfolio
-
Black Rock Inc. New York, NY2.34MShares$4.15 Million0.0% of portfolio
-
Aisling Capital Management LP New York, NY2.05MShares$3.63 Million1.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.88MShares$3.33 Million0.0% of portfolio
About Biomea Fusion, Inc.
- Ticker BMEA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,290,600
- Market Cap $51.8M
- Description
- Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...